ArticleMolecular cancer research : MCR2019

GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.

Samantha M Bevill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.